
1. transpl infect dis. 2018 aug;20(4):e12926. doi: 10.1111/tid.12926. epub 2018 jun 
22.

community-acquired respiratory virus lower respiratory tract disease in
allogeneic stem cell transplantation recipient: risk factors mortality from
pulmonary virus-bacterial mixed infections.

piñana jl(1)(2), gómez md(3), pérez a(4), madrid s(5), balaguer-roselló a(1),
giménez e(5), montoro j(1)(2), gonzález em(3), vinuesa v(5), moles p(6),
hernández-boluda jc(4), salavert m(7), calabuig m(4), sanz g(1)(2), solano
c(4)(8), sanz j(1)(2), navarro d(5)(9).

author information: 
(1)hematology department, hospital universitari politècnic la fe, valencia,
spain.
(2)instituto carlos iii, ciberonc, madrid, spain.
(3)microbiology department, hospital universitari politècnic la fe, valencia,
spain.
(4)hematology department, institute research incliva, hospital clínico
universitario, valencia, spain.
(5)microbiology department, institute research incliva, hospital clínico
universitario, valencia, spain.
(6)dermatology department, hospital universitari politècnic la fe, valencia,
spain.
(7)department infectious diseases, hospital universitari politècnic la fe,
valencia, spain.
(8)department medicine, school medicine, university valencia, valencia, 
spain.
(9)department microbiology, school medicine, university valencia,
valencia, spain.

risk factors (rfs) mortality data community-acquired respiratory virus
(carvs) lower respiratory tract disease (lrtd) concurrent pulmonary
co-infections setting allogeneic hematopoietic stem cell
transplantation (allo-hsct) scarce. january 2011 december 2017, we
retrospectively compared outcome allo-hsct recipients diagnosed carvs
lrtd mono-infection (n = 52, group 1), viral, bacterial, fungal 
pulmonary carvs lrtd co-infections (n = 15, group 2; n = 20, group 3, n = 11,
group 4, respectively), bacterial pneumonia mono-infection 
(n = 19, group 5). overall survival (os) day 60 bronchoalveolar lavage
(bal) significantly higher group 1, 2, 4 compared group 3 (77%,
67%, 73% vs 35%, respectively, p = .012). recipients group 5 showed a
trend better os compared group 3 (62% vs 35%, p = .1).
multivariate analyses showed bacterial co-infection rf mortality (hazard
ratio[hr] 2.65, 95% c.i. 1.2-6.9, p = .017). identified 3 rfs for
mortality: lymphocyte count <0.5 × 109 /l (hr 2.6, 95% 1.1-6.2, p = .026), the
occurrence cmv dnaemia requiring antiviral therapy (cmv-dnaemia-rat) at
the time bal (hr 2.32, 95% c.i. 1.1-4.9, p = .03), need oxygen
support (hr 8.3, 95% c.i. 2.9-35.3, p = .004). carv lrtd co-infections are
frequent may negative effect outcome, particular the
context bacterial co-infections.

© 2018 john wiley & sons a/s. published john wiley & sons ltd.

doi: 10.1111/tid.12926 
pmcid: pmc7169706
pmid: 29809298  [indexed medline]

